A carregar...
Interleukin-6: From arthritis to CAR-T cell therapy and COVID-19
Blockade of interleukin (IL)-6 function by an anti-IL-6 receptor (IL-6R) antibody (tocilizumab, trade name Actemra) has been shown to be effective for the treatment of chronic autoimmune inflammatory diseases including rheumatoid arthritis. Interestingly, treatment with tocilizumab has also been fou...
Na minha lista:
| Publicado no: | Int Immunol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7989346/ https://ncbi.nlm.nih.gov/pubmed/33715009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/intimm/dxab011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|